Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: A case-control and cohort study

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Osthoff, Michael ^a,b   Ngian, Gene Siew ^a,b,c   Dean, Melinda M ^d   Nikpour, Mandana ^e   Stevens, Wendy ^e   Proudman, Susanna ^f,g   Eisen, Damon P ^a,b   Sahhar, Joanne ^c,h  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f ROYAL ADELAIDE HOSPITAL   (Australia)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FICOLIN; FICOLIN 2; ILOPROST; MANNOSE BINDING LECTIN; SCL 70 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; EXON; FEMALE; FORCED VITAL CAPACITY; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOGENESIS; PROTEIN BLOOD LEVEL; RAYNAUD PHENOMENON; SCLERODERMA; SCLERODERMA HEALTH ASSESSMENT QUESTIONNAIRE; SYSTEMIC SCLEROSIS;

EID: 84924616206     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0480-6     Document Type: Article

References (51)

1. Elhai M, Meune C, Avouac J, Kahan A, Allanore Y: Trends in mortality in patients with systemic sclerosis over 40years: a systematic review and meta-analysis of cohort studies. Rheumatology 2012, 51:1017-1026.
2. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
3. Martin JE, Bossini-Castillo L, Martin J: Unraveling the genetic component of systemic sclerosis. Hum Genet 2012, 131:1023-1037.
4. Dinkler M: Zur Lehre von der Sklerodermie. Deutsch Arch Klin Med 1891, 48:514-577.
5. Matucci-Cerinic M, Kahaleh B, Wigley FM: Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013, 65:1953-1962.
6. Gabrielli A, Avvedimento EV, Krieg T: Scleroderma. N Engl J Med 2009, 360:1989-2003.
7. Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Muller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, et al: Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010, 69:1809-1815.
8. Benbassat C, Schlesinger M, Luderschmidt C, Valentini G, Tirri G, Shoenfeld Y: The complement system and systemic sclerosis. Immunol Res 1993, 12:312-316.
9. Hudson M, Walker JG, Fritzler M, Taillefer S, Baron M: Hypocomplementemia in systemic sclerosis-clinical and serological correlations. J Rheumatol 2007, 34:2218-2223.
10. Kjaer TR, Thiel S, Andersen GR: Toward a structure-based comprehension of the lectin pathway of complement. Mol Immunol 2013, 56:413-422.
11. Gulla KC, Gupta K, Krarup A, Gal P, Schwaeble WJ, Sim RB, O'Connor CD, Hajela K: Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology 2010, 129:482-495.
12. La Bonte LR, Pavlov VI, Tan YS, Takahashi K, Takahashi M, Banda NK, Zou C, Fujita T, Stahl GL: Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis. J Immunol 2012, 188:885-891.
13. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO: Mannose-binding lectin and its genetic variants. Genes Immun 2006, 7:85-94.
14. Kilpatrick DC, St Swierzko A, Matsushita M, Domzalska-Popadiuk I, Borkowska-Klos M, Szczapa J, Cedzynski M: The relationship between FCN2 genotypes and serum ficolin-2 (L-ficolin) protein concentrations from a large cohort of neonates. Hum Immunol 2013, 74:867-871.
15. Davies EJ, Snowden N, Hillarby MC, Carthy D, Grennan DM, Thomson W, Ollier WE: Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995, 38:110-114.
16. Schoos MM, Munthe-Fog L, Skjoedt MO, Ripa RS, Lonborg J, Kastrup J, Kelbaek H, Clemmensen P, Garred P: Association between lectin complement pathway initiators, C-reactive protein and left ventricular remodeling in myocardial infarction-a magnetic resonance study. Mol Immunol 2013, 54:408-414.
17. Cervera A, Planas AM, Justicia C, Urra X, Jensenius JC, Torres F, Lozano F, Chamorro A: Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS One 2010, 5:e8433.
18. Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse ML, Ziere B, Gobbi M, De Simoni MG: Recombinant C1 inhibitor in brain ischemic injury. Ann Neurol 2009, 66:332-342.
19. Walsh MC, Bourcier T, Takahashi K, Shi L, Busche MN, Rother RP, Solomon SD, Ezekowitz RA, Stahl GL: Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 2005, 175:541-546.
20. Schwaeble WJ, Lynch NJ, Clark JE, Marber M, Samani NJ, Ali YM, Dudler T, Parent B, Lhotta K, Wallis R, Farrar CA, Sacks S, Lee H, Zhang M, Iwaki D, Takahashi M, Fujita T, Tedford CE, Stover CM: Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 2011, 108:7523-7528.
21. Orsini F, Villa P, Parrella S, Zangari R, Zanier ER, Gesuete R, Stravalaci M, Fumagalli S, Ottria R, Reina JJ, Paladini A, Micotti E, Ribeiro-Viana R, Rojo J, Pavlov VI, Stahl GL, Bernardi A, Gobbi M, De Simoni MG: Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia. Circulation 2012, 126:1484-1494.
22. Trendelenburg M, Theroux P, Stebbins A, Granger C, Armstrong P, Pfisterer M: Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J 2010, 31:1181-1187.
23. Osthoff M, Katan M, Fluri F, Schuetz P, Bingisser R, Kappos L, Steck AJ, Engelter ST, Mueller B, Christ-Crain M, Trendelenburg M: Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS One 2011, 6:e21338.
24. Masi AT, Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590.
25. LeRoy EC, Medsger TA Jr: Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
26. Alarcon-Segovia D, Cardiel MH: Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989, 16:328-334.
27. Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG: Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002, 56:630-641.
28. Hein E, Bay JT, Munthe-Fog L, Garred P: Ficolin-2 reveals different analytical and biological properties dependent on different sample handling procedures. Mol Immunol 2013, 56:406-412.
29. Brady AM, Spencer BL, Falsey AR, Nahm MH: Blood collection tubes influence serum ficolin-1 and ficolin-2 levels. Clin Vaccine Immunol 2014, 21:51-55.
30. Osthoff M, Au Yong HM, Dean MM, Eisen DP: Significance of mannose-binding lectin deficiency and nucleotide-binding oligomerization domain 2 polymorphisms in staphylococcus aureus bloodstream infections: a case-control study. PLoS One 2013, 8:e76218.
31. Eisen DP, Dean MM, Boermeester MA, Fidler KJ, Gordon AC, Kronborg G, Kun JF, Lau YL, Payeras A, Valdimarsson H, Brett SJ, Ip WK, Mila J, Peters MJ, Saevarsdottir S, van Till JW, Hinds CJ, McBryde ES: Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 2008, 47:510-516.
32. Ouf EA, Ojurongbe O, Akindele AA, Sina-Agbaje OR, Van Tong H, Adeyeba AO, Kremsner PG, Kun JF, Velavan T: Ficolin-2 levels and FCN2 genetic polymorphisms as a susceptibility factor in schistosomiasis. J Infect Dis 2012, 206:562-570.
33. Zhou X, Lee JE, Arnett FC, Xiong M, Park MY, Yoo YK, Shin ES, Reveille JD, Mayes MD, Kim JH, Song R, Choi JY, Park JA, Lee YJ, Lee EY, Song YW, Lee EB: HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum 2009, 60:3807-3814.
34. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, Coenen MJ, Vonk MC, Voskuyl AE, Schuerwegh AJ, Broen JC, van Riel PL, van't Slot R, Italiaander A, Ophoff RA, Riemekasten G, Hunzelmann N, Simeon CP, Ortego-Centeno N, González-Gay MA, González-Escribano MF, Spanish Scleroderma Group, Airo P, van Laar J, Herrick A, Worthington J, Hesselstrand R, Smith V, de Keyser F, Houssiau F, et al: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010, 42:426-429.
35. Allanore Y, Saad M, Dieude P, Avouac J, Distler JH, Amouyel P, Matucci-Cerinic M, Riemekasten G, Airo P, Melchers I, Hachulla E, Cusi D, Wichmann HE, Wipff J, Lambert JC, Hunzelmann N, Tiev K, Caramaschi P, Diot E, Kowal-Bielecka O, Valentini G, Mouthon L, Czirják L, Damjanov N, Salvi E, Conti C, Müller M, Müller-Ladner U, Riccieri V, Ruiz B, et al: Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 2011, 7:e1002091.
36. Potlukova E, Jiskra J, Freiberger T, Limanova Z, Zivorova D, Malickova K, Springer D, Grodecka L, Antosova M, Telicka Z, Pesickova SS, Trendelenburg M: The production of mannan-binding lectin is dependent upon thyroid hormones regardless of the genotype: a cohort study of 95 patients with autoimmune thyroid disorders. Clin Immunol 2010, 136:123-129.
37. Altorjay I, Vitalis Z, Tornai I, Palatka K, Kacska S, Farkas G, Udvardy M, Harsfalvi J, Dinya T, Orosz P, Lombay B Jr, Par G, Par A, Csak T, Osztovits J, Szalay F, Csepregi A, Lakatos PL, Papp M: Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis. J Hepatol 2010, 53:484-491.
38. van der Pol P, Schlagwein N, van Gijlswijk DJ, Berger SP, Roos A, Bajema IM, de Boer HC, de Fijter JW, Stahl GL, Daha MR, van Kooten C: Mannan-binding lectin mediates renal ischemia/reperfusion injury independent of complement activation. Am J Transplant 2012, 12:877-887.
39. Osthoff M, Trendelenburg M: Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction. Biomed Res Int 2013, 2013:962695.
40. Venneker GT, van den Hoogen FH, Boerbooms AM, Bos JD, Asghar SS: Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage. Lab Invest 1994, 70:830-835.
41. Sprott H, Muller-Ladner U, Distler O, Gay RE, Barnum SR, Landthaler M, Scholmerich J, Lang B, Gay S: Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma). J Rheumatol 2000, 27:402-404.
42. Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, Diaz-Gallo LM, Broen JC, Vonk MC, Simeon CP, Alizadeh BZ, Coenen MJ, Voskuyl AE, Schuerwegh AJ, van Riel PL, Vanthuyne M, van't Slot R, Italiaander A, Ophoff RA, Hunzelmann N, Fonollosa V, Ortego-Centeno N, González-Gay MA, García-Hernández FJ, González-Escribano MF, Airo P, van Laar J, Worthington J, Hesselstrand R, Smith V, et al: Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 2011, 7:e1002178.
43. Furst D, Khanna D, Matucci-Cerinic M, Clements P, Steen V, Pope J, Merkel P, Foeldvari I, Seibold J, Pittrow D, Polisson R, Strand V: Systemic sclerosis - continuing progress in developing clinical measures of response. J Rheumatol 2007, 34:1194-1200.
44. Leach HG, Chrobak I, Han R, Trojanowska M: Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury. Am J Respir Cell Mol Biol 2013, 49:1093-1101.
45. Collard CD, Vakeva A, Morrissey MA, Agah A, Rollins SA, Reenstra WR, Buras JA, Meri S, Stahl GL: Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 2000, 156:1549-1556.
46. Davis AE 3rd, Cai S, Liu D: C1 inhibitor: biologic activities that are independent of protease inhibition. Immunobiology 2007, 212:313-323.
47. Castellano G, Melchiorre R, Loverre A, Ditonno P, Montinaro V, Rossini M, Divella C, Battaglia M, Lucarelli G, Annunziata G, Palazzo S, Selvaggi FP, Staffieri F, Crovace A, Daha MR, Mannesse M, van Wetering S, Paolo Schena F, Grandaliano G: Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol 2010, 176:1648-1659.
48. Senaldi G, Lupoli S, Vergani D, Black CM: Activation of the complement system in systemic sclerosis. Relationship to clinical severity. Arthritis Rheum 1989, 32:1262-1267.
49. Foocharoen C, Distler O, Becker M, Muller-Ladner U, von Muhlen C, Leuchten N, Walker UA: Clinical correlations of hypocomplementaemia in systemic sclerosis: an analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) database. Scand J Rheumatol 2012, 41:243-246.
50. Akamata K, Asano Y, Aozasa N, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Kadono T, Sato S: Serum levels of mannose-binding lectin in systemic sclerosis: a possible contribution to the initiation of skin sclerosis in the diffuse cutaneous subtype. Eur J Dermatol 2014, 24:123-125.
51. Reveille JD: Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep 2003, 5:160-167.